Literature DB >> 12480710

Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage.

Takami Yurugi-Kobayashi1, Hiroshi Itoh, Jun Yamashita, Kenichi Yamahara, Hideyo Hirai, Takuya Kobayashi, Minetaro Ogawa, Satomi Nishikawa, Shin-Ichi Nishikawa, Kazuwa Nakao.   

Abstract

We demonstrated that Flk-1(+) cells derived from mouse embryonic stem (ES) cells can differentiate into both endothelial cells (ECs) and mural cells (MCs) to suffice as vascular progenitor cells (VPCs). In the present study, we investigated the importance of the stage of ES cell differentiation on effective participation in adult neovascularization. We obtained Flk-1(+) LacZ-expressing undifferentiated VPCs. Additional culture of these VPCs with vascular endothelial growth factor (VEGF) resulted in a mixture of ECs and MCs (differentiated VPCs). We injected VPCs subcutaneously into tumor-bearing mice. Five days after the injection, whereas undifferentiated VPCs were often detected as nonvascular cells, differentiated VPCs were more specifically incorporated into developing vasculature mainly as ECs. VPC-derived MCs were also detected in vascular walls. Furthermore, transplantation of differentiated VPCs augmented tumor blood flow in nude mice. These results indicate that a specific vascular contribution in adult neovascularization can be achieved by selective transplantation of ES cell-derived VPCs in appropriate differentiation stages, which should be the basis for vascular regeneration schemes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480710     DOI: 10.1182/blood-2002-06-1877

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo; Jiang F Zhong; William G Loudon
Journal:  World J Stem Cells       Date:  2011-09-26       Impact factor: 5.326

Review 2.  Abnormal tumor vasculatures and bone marrow-derived pro-angiogenic cells in cancer.

Authors:  Yusuke Mizukami; Junpei Sasajima; Toshifumi Ashida; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2012-02-07       Impact factor: 2.490

Review 3.  Biologic properties of endothelial progenitor cells and their potential for cell therapy.

Authors:  Pampee P Young; Douglas E Vaughan; Antonis K Hatzopoulos
Journal:  Prog Cardiovasc Dis       Date:  2007 May-Jun       Impact factor: 8.194

Review 4.  Differentiation of mesodermal cells from pluripotent stem cells.

Authors:  Michinori Kitagawa; Takumi Era
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

5.  Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading.

Authors:  Haiying Huang; Yasuhide Nakayama; Kairong Qin; Kimiko Yamamoto; Joji Ando; Jun Yamashita; Hiroshi Itoh; Keiichi Kanda; Hitoshi Yaku; Yoshihiro Okamoto; Yasushi Nemoto
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

Review 6.  Normalization of the vasculature for treatment of cancer and other diseases.

Authors:  Shom Goel; Dan G Duda; Lei Xu; Lance L Munn; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

7.  p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.

Authors:  R Fernandez-Alonso; M Martin-Lopez; L Gonzalez-Cano; S Garcia; F Castrillo; I Diez-Prieto; A Fernandez-Corona; M E Lorenzo-Marcos; X Li; L Claesson-Welsh; M M Marques; M C Marin
Journal:  Cell Death Differ       Date:  2015-01-09       Impact factor: 15.828

8.  Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.

Authors:  Junpei Sasajima; Yusuke Mizukami; Yoshiaki Sugiyama; Kazumasa Nakamura; Toru Kawamoto; Kazuya Koizumi; Rie Fujii; Wataru Motomura; Kazuya Sato; Yasuaki Suzuki; Satoshi Tanno; Mikihiro Fujiya; Katsunori Sasaki; Norihiko Shimizu; Hidenori Karasaki; Toru Kono; Jun-ichi Kawabe; Masaaki Ii; Hiroki Yoshiara; Naohisa Kamiyama; Toshifumi Ashida; Nabeel Bardeesy; Daniel C Chung; Yutaka Kohgo
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

Review 9.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

10.  Hemodynamic forces regulate embryonic stem cell commitment to vascular progenitors.

Authors:  Tzung K Hsiai; Joseph C Wu
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.